Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure

International Journal of Pharmaceutics

Volumn 406, Issue 1-2, 2011, Pages 163-172

  Kovacevic, A ^a   Savic, S ^a   Vuleta, G ^a   Muller R H ^b   Keck, C M ^c,d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

^d UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Crystallinity; Nanostructured lipid carriers; NLC; Physical stability; Polyhydroxy surfactants; SLN; Solid lipid nanoparticles

Indexed keywords

CAPRYL GLUCOSIDE; CAPRYLYL GLUCOSIDE; DRUG CARRIER; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; POLYGLYCEROL 6 DISTEARATE; SOLID LIPID NANOPARTICLE; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; HYDROPHOBICITY; LASER DIFFRACTION; LIPOPHILICITY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; ROOM TEMPERATURE; ZETA POTENTIAL;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG STABILITY; DRUG STORAGE; GLUCANS; GLYCEROL; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPIDS; MOLECULAR STRUCTURE; NANOPARTICLES; PALMITATES; PARTICLE SIZE; POLYMERS; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES;

EID: 79951578183     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.12.036     Document Type: Article

References (47)

1. P. Ahlin, J. Kristl, M. Sentjurc, J. Strancar, and S. Pecar Influence of spin probe structure on its distribution in SLN dispersions Int. J. Pharm. 196 2000 241 244 (Pubitemid 30105752)
2. A.A. Attama, B.C. Schicke, T. Paepenmüller, and C.C. Müller-Goymann Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization Eur. J. Pharm. Biopharm. 67 2007 48 57 (Pubitemid 46991314)
3. P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Deliv. Rev. 59 2007 454 477 (Pubitemid 47259226)
4. H. Bunjes, M.H. Koch, and K. Westesen Effects of surfactants on the crystallization and polymorphism of lipid nanoparticles Prog. Colloid Polym. Sci. 121 2002 7 10
5. H. Bunjes, M.H. Koch, and K. Westesen Influence of emulsifiers on the crystallization of solid lipid nanoparticles J. Pharm. Sci. 92 2003 1509 1520 (Pubitemid 36792763)
6. Cosmetic Ingredient Reviews Final report on the safety assessment of PEG-2, -3, -5, -10, -15, and -20 cocamine Int. J. Toxicol. 18 1999 43 50
7. C. Freitas, and R.H. Müller Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132 (Pubitemid 29185115)
8. N. Garti, and J. Yano The roles of emulsifiers in fat crystallization K. Sato, S. Garti, Crystallization Processes in Fats and Lipid Systems 2001 Marcel Dekker New York 211 250
9. W. Johnson Jr. Final report on the safety assessment of PEG-25 propylene glycol stearate, PEG-75 propylene glycol stearate, PEG-120 propylene glycol stearate, PEG-10 propylene glycol PEG-8 propylene glycol cocoate, and PEG-55 propylene glycol oleate Int. J. Toxicol. 20 Suppl. 4 2001 13 26 (Pubitemid 34056789)
10. K. Jores, A. Haberland, S. Wartewig, K. Mäder, and W. Mehnert Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy Pharm. Res. 22 2005 1887 1897 (Pubitemid 41504342)
11. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, and K. Mäder Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy J. Control. Rel. 95 2004 217 227 (Pubitemid 38230037)
12. M.D. Joshi, and R.H. Müller Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71 2009 161 172
13. C.M. Keck, and R.H. Müller Size analysis of submicron particles by laser diffractometry - 90% of the published measurements are false Int. J. Pharm. 355 2008 150 163
14. R.S. Lanigan, and T.A. Yamarik Final report on the safety assessment of PEG-6, -8, and -20 sorbitan beeswax Int. J. Toxicol. 20 2001 27 38
15. X. Lin, X. Li, L. Zheng, L. Yu, Q. Zhang, and W. Liu Preparation and characterization of monocaprate nanostructured lipid carriers Colloid Surf. A: Physicochem. Eng. Aspects 311 2007 106 111 (Pubitemid 350026290)
16. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chen, Q. Zhang, Q. He, and Z. Zhang Solid lipid nanoparticles for pulmonary delivery of insulin Int. J. Pharm. 356 2008 333 344
17. S. Lombardi Borgia, M. Regehly, R. Sivaramakrishnan, W. Mehnert, H.C. Korting, K. Danker, B. Röder, K.D. Kramer, and M. Schäfer-Korting Lipid nanoparticles for skin penetration enhancement - correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy J. Control. Rel. 110 2005 151 163 (Pubitemid 41713939)
18. S. Lombardi Borgia, P. Schlupp, W. Mehnert, and M. Schäfer-Korting In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use Eur. J. Pharm. Biopharm. 2007
19. Lucks, J.S., Müller, R.H., 1996. Medication vehicles made of solid lipid particle (solid lipid Nanospheres - SLN), European Patent EP0000605497.
20. W. Mehnert, and K. Mäder Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196 (Pubitemid 32324113)
21. M. Muchow, P. Maincent, and R.H. Müller Lipid nanoparticles with a solid matrix (SLN, NLC LDC) for oral drug delivery Drug Dev. Ind. Pharm. 34 2008 1394 1405
22. R.H. Müller Zetapotential und Partikeladung in der Laborpraxis. Wissenschaftliche Verlagsgeselschaft mbH 1996 Suttgart
23. R.H. Müller, V. Jenning, K. Mäder, and A. Lippacher Lipid Particles on the Basis of Mixtures of Liquid and Solid Lipids and the Method for Producing same, PCT/EP2000/004112 2000 PharmaSol GmbH Germany
24. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177 (Pubitemid 30326695)
25. R.H. Müller, W. Mehnert, J.S. Lucks, C. Schwarz, A. zur Mühlen, and Weyhers H., Freitas, C., Rühl, D. Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery Eur. J. Pharm. Biopharm. 41 1995 62 69
26. R.H. Müller, R.D. Petersen, A. Hommoss, and J. Pardeike Nanostructured lipid carriers (NLC) in cosmetic dermal products Adv. Drug Deliv. Rev. 59 2007 522 530 (Pubitemid 47271894)
27. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
28. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 S131 155
29. R.H. Müller, S. Runge, V. Ravelli, W. Mehnert, A.F. Thünemann, and E.B. Souto Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals Int. J. Pharm. 317 2006 82 89 (Pubitemid 43866342)
30. J. Pardeike, A. Hommoss, and R.H. Müller Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 2009 170 184
31. M. Perez Gibbs-Thomson effects in phase transformations Scripta Mater. 52 2005 709 712 (Pubitemid 40183329)
32. Rawle, A. Basic principles of particle size analysis. Online article, www.malvern.com.
33. T.M. Riddick Control of Colloid Stability through Zeta Potential 1968 Zeta-Meter Inc. via Livingston Publishing Company Wynnewood
34. C. Santos Maia, W. Mehnert, M. Schaller, H.C. Korting, A. Gysler, A. Haberland, and M. Schäfer-Korting Drug targeting by solid lipid nanoparticles for dermal use J. Drug Target. 10 2002 489 495 (Pubitemid 35230199)
35. B. Sarmento, S. Martins, D. Ferreira, and E.B. Souto Oral insulin delivery by means of solid lipid nanoparticles Int. J. Nanomed. 2 2007 743 749
36. A. Saupe, S.A. Wissing, A. Lenk, C. Schmidt, and R.H. Müller Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) - structural investigations on two different carrier systems Biomed. Mater. Eng. 15 2005 393 402 (Pubitemid 41330513)
37. Siekmann, B., 1994. Untersuchungen zur Herstellung und zum Rekristallisationsverhalten schmelzemulgierter intravenös applizierbarerGlyceridnanopartikel. Ph.D. Thesis, Technische Universität Carlo Wilhelmina Braunschweig.
38. B. Siekmann, and K. Westesen Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination Pharm. Pharmacol. Lett. 3 1994 194 197
39. B. Siekmann, and K. Westesen Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. II. Physicochemical characterization and lyophilisation Pharm. Pharmacol. Lett. 3 1994 225 228
40. O. Söderman, and I. Johansson Polyhydroxyl-based surfactants and their physico-chemical properties and applications Curr. Opin. Colloid Interface Sci. 4 1999 391 401 (Pubitemid 30449766)
41. Souto, E.B., 2005. SLN and NLC for Topical Delivery of Antifungals. Ph.D. Thesis, Freie Universität Berlin.
42. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Müller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 2004 71 77 (Pubitemid 38670438)
43. J. Stecova, W. Mehnert, T. Blaschke, B. Kleuser, R. Sivaramakrishnan, C.C. Zouboulis, H. Seltmann, H.C. Korting, K.D. Kramer, and M. Schäfer-Korting Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake Pharm. Res. 24 2007 991 1000 (Pubitemid 46675401)
44. T.F. Tadros Applied Surfactants - Principles and Applications 2005 Wiley VHC Weinheim
45. E. Ugazio, R. Cavalli, and M.R. Gasco Incorporation of cyclosporin A in solid lipid nanoparticles (SLN) Int. J. Pharm. 241 2002 341 344 (Pubitemid 34718035)
46. K. Westesen, B. Siekmann, and M.H. Koch Investigations on the physical state of lipid nanoparticles by synchron X-ray diffraction Int. J. Pharm. 93 1993 189 199 (Pubitemid 23181296)
47. S.A. Wissing, O. Kayser, and R.H. Müller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272 (Pubitemid 38510473)